Qiuhe Ji

Government of the People's Republic of China - Fourth Military Medical University

China

SCHOLARLY PAPERS

2

DOWNLOADS

14

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Efficacy and Safety of the Peroxisome Proliferator-Activated Receptor Pan-Agonist Chiglitazar in Patients with Type 2 Diabetes (CMAP): A 24 Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase 3 Superiority Trial

Number of pages: 100 Posted: 21 Aug 2019
Peking University - Department of Endocrinology and Metabolism, Southern Medical University - Chenzhou No.1 People's Hospital, Tangshan Gongren Hospital, Xuzhou Medical University, Harrison International Peace Hospital, Qingdao University - Affiliated Hospital, China Three Gorges University (CTGU) - College of Medical Science, Jilin University (JLU) - Second Hospital, Jiangsu Province Hospital, China Meitan General Hospital, Chongqing University, Chongqing Medical University - First Affiliated Hospital, Hebei Medical University, Tianjin Medical University - General Hospital, Government of the People's Republic of China - 306th Hospital, Baogang Hospital of Inner Mongolia, Cangzhou Central Hospital, Fudan University - Zhongshan Hospital, Sichuan University, Government of the People's Republic of China - Fourth Military Medical University, Shanghai Jiao Tong University (SJTU) - Xinhua Hospital, Central South University - Department of Endocrinology and Metabolism, Peking University, Central South University - Second Xiangya Hospital, Xiamen University - First Affiliated Hospital, Wuhan University - Zhongnan Hospital, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd, Chipscreen Biosciences Ltd and Shanghai Jiao Tong University (SJTU) - Shanghai Diabetes Institute
Downloads 9 (601,846)

Abstract:

Loading...

2.

Prevalence and Identification of Type 1 Diabetes in Chinese Adults with Newly-Diagnosed Diabetes

Number of pages: 35 Posted: 25 Oct 2018
Central South University - Department of Endocrinology and Metabolism, Central South University, Central South University, Central South University, Central South University, Central South University, Tianjin Medical University, Changzhi Medical College, Gansu Provincial Hospital, Yangzhou University - Northern Jiangsu People's Hospital, Hainan General Hospital - Department of Endocrinology, Wenzhou Medical University, Fujian Medical University - Union Hospital, University of South China, Nanjing Medical University - Nanjing Medical Hospital, Henan University of Science and Technology, The First People’s Hospital of Huaihua, University of South China, Kunming University of Science and Technology - First People’s Hospital of Yunnan Province, The First People’s Hospital of Changde City, Government of the People's Republic of China - Dongguan Third People’s Hospital, Fujian Medical University - Union Hospital, Inner Mongolia Medical University, Central South University, Chongqing Medical University - First Affiliated Hospital, The First People’s Hospital of YueYang, Government of the People's Republic of China - Beijing Hospital, Guangxi Medical University, Guangdong Academy of Medical Sciences - Guangdong General Hospital, Tangshan Gongren Hospital, South China University of Technology - Guangzhou First People’s Hospital, Nanjing Medical University - Nanjing Medical Hospital, China Medical University - Department of Endocrinology and Metabolism, Government of the People's Republic of China - Fourth Military Medical University, Peking University - Department of Endocrinology and Metabolism, Central South University - Department of Endocrinology and Metabolism and affiliation not provided to SSRN
Downloads 5 (628,466)

Abstract:

Loading...

Type 1 Diabetes Mellitus; Latent Autoimmune Diabetes in Adults; Type 2 Diabetes; Newly-Diagnosed Diabetes; Prevalence